XBI Holdings Information

XBI is an equity ETF with a total of 129 individual holdings. The top holdings are Alnylam Pharmaceuticals stock at 3.61%, Halozyme Therapeutics at 3.06%, Insmed at 3.06%, Incyte at 2.92%, and United Therapeutics at 2.67%.

Total Holdings

129

Top 10 Percentage

27.96%

Asset Class

Equity

ETF Category

Health

Assets

5.40B

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ALNY	Alnylam Pharmaceuticals, Inc.	3.61%	399,545
2	HALO	Halozyme Therapeutics, Inc.	3.06%	2,215,302
3	INSM	Insmed Incorporated	3.06%	1,217,565
4	INCY	Incyte Corporation	2.92%	1,732,792
5	UTHR	United Therapeutics Corporation	2.67%	431,445
6	REGN	Regeneron Pharmaceuticals, Inc.	2.60%	230,023
7	GILD	Gilead Sciences, Inc.	2.54%	1,091,558
8	ABBV	AbbVie Inc.	2.53%	622,975
9	NBIX	Neurocrine Biosciences, Inc.	2.52%	960,740
10	BIIB	Biogen Inc.	2.46%	896,533
11	AMGN	Amgen Inc.	2.38%	408,760
12	MRNA	Moderna, Inc.	2.37%	4,298,962
13	BMRN	BioMarin Pharmaceutical Inc.	2.36%	2,087,086
14	BBIO	BridgeBio Pharma, Inc.	2.36%	2,442,140
15	MDGL	Madrigal Pharmaceuticals, Inc.	2.28%	304,610
16	NTRA	Natera, Inc.	2.26%	715,413
17	EXEL	Exelixis, Inc.	2.13%	2,879,598
18	VRTX	Vertex Pharmaceuticals Incorporated	2.03%	263,733
19	EXAS	Exact Sciences Corporation	1.93%	2,143,448
20	ROIV	Roivant Sciences Ltd.	1.70%	7,333,642
21	CYTK	Cytokinetics, Incorporated	1.57%	2,103,686
22	CRSP	CRISPR Therapeutics AG	1.52%	1,419,162
23	IONS	Ionis Pharmaceuticals, Inc.	1.51%	1,796,881
24	RVMD	Revolution Medicines, Inc.	1.37%	1,898,726
25	RNA	Avidity Biosciences, Inc.	1.37%	1,574,988

As of Aug 19, 2025

Showing 25 of 129

Subscribe to see the full list